Candriam Luxembourg S.C.A. »

Biohaven shares owned by Candriam Luxembourg S.C.A.

Quarter-by-quarter ownership of Biohaven (BHVN) shares owned by Candriam Luxembourg S.C.A. from 13F filings

Historical chart of Candriam Luxembourg S.C.A. investment in Biohaven

Tip: Access up to 7 years of quarterly data

All positions including Biohaven held by Candriam Luxembourg S.C.A. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biohaven by Candriam Luxembourg S.C.A.

Quarter filed Position value Share count Share price at filing
2024-03-31 $5.5M 100k 54.69

More positions owned by Candriam Luxembourg S.C.A.

Vipshop Hldgs Sponsored Ads A (Principal) (VIPS)
Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Merck & Co (MRK)
Eli Lilly & Co. (LLY)
Thermo Fisher Scientific (TMO)
Amazon (AMZN)
Visa Com Cl A (V)
Regeneron Pharmaceuticals (REGN)
Amgen (AMGN)
UnitedHealth (UNH)
Mastercard Incorporated Cl A (MA)
salesforce (CRM)

View all positions for Candriam Luxembourg S.C.A.

Top funds holding Biohaven

Vanguard Group
Stifel Financial
BlackRock
Henderson Group
Suvretta Capital Management
T. Rowe Price Associates
RP Management
Adage Capital Partners GP
Perceptive Advisors
FMR
Geode Capital Management
Darwin Global Management
Citadel Advisors
Holocene Advisors
T. Rowe Price Investment Management

View all funds holding Biohaven